PSA, an outdated biomarker for prostate cancer: In search of a more specific biomarker, citrate takes the spotlight
The prevailing biomarker employed for prostate cancer (PCa) screening and diagnosis is the prostate-specific antigen (PSA). Despite excellent sensitivity, PSA lacks specificity, leading to false positives, unnecessary biopsies and overdiagnosis. Consequently, PSA is increasingly less used by clinici...
Gespeichert in:
Veröffentlicht in: | The Journal of steroid biochemistry and molecular biology 2024-10, Vol.243, p.106588, Article 106588 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!